p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541. (Q46058206)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541. |
scientific article |
Statements
1 reference
p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541. (English)
1 reference
1 reference
Emili Montserrat
1 reference
Mónica López-Guerra
1 reference
Patricia Pérez-Galán
1 reference
Roberto Alonso
1 reference
Neus Villamor
1 reference
7 April 2009
1 reference
15
1 reference
8
1 reference
2767-2776
1 reference